1. Home
2. Information
3. Highlights and News

Highlights and News

New data reveals ethnic disparities in early rheumatoid arthritis treatment - University of Birmingham

New data reveals ethnic disparities in early rheumatoid arthritis treatment  University of Birmingham

Augurex Announces UK Conformity Assessed (UKCA) Authorization for JOINTstat - Business Wire

Augurex Announces UK Conformity Assessed (UKCA) Authorization for JOINTstat  Business Wire

Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study - The Lancet

Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study  The Lancet

Rheumatoid Arthritis Life Expectancy: What You Need to Know - HealthCentral

Rheumatoid Arthritis Life Expectancy: What You Need to Know  HealthCentral

Asian and older rheumatoid arthritis sufferers 50% less likely to receive targeted treatment, finds study - Medical Xpress

Asian and older rheumatoid arthritis sufferers 50% less likely to receive targeted treatment, finds study  Medical Xpress

Cell detectives offer clues to counter rheumatoid arthritis flare-ups - Laboratory News

Cell detectives offer clues to counter rheumatoid arthritis flare-ups  Laboratory News

Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes - ScienceDirect.com

Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes  ScienceDirect.com

Nurse-led care for people with early rheumatoid arthritis: Interview study with thematic analysis - Wiley Online Library

Nurse-led care for people with early rheumatoid arthritis: Interview study with thematic analysis  Wiley Online Library

Impact of Rheumatoid Arthritis and Its Management on Falls, Fracture and Bone Mineral Density in UK Biobank - Frontiers

Impact of Rheumatoid Arthritis and Its Management on Falls, Fracture and Bone Mineral Density in UK Biobank  Frontiers

Clinical Trials and Resources - Arthritis Foundation

Clinical Trials and Resources  Arthritis Foundation

Rheumatoid Arthritis: Autoimmune Joint Inflammation - HSS | Hospital for Special Surgery

Rheumatoid Arthritis: Autoimmune Joint Inflammation  HSS | Hospital for Special Surgery

11 Signs Your Rheumatoid Arthritis May Be Getting Worse, and You Should See a Doctor - CreakyJoints

11 Signs Your Rheumatoid Arthritis May Be Getting Worse, and You Should See a Doctor  CreakyJoints

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients - Nature

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients  Nature

Rheumatoid arthritis: features, causes and diagnosis - The Pharmaceutical Journal

Rheumatoid arthritis: features, causes and diagnosis  The Pharmaceutical Journal

Treatment to target in rheumatoid arthritis - Nursing Times

Treatment to target in rheumatoid arthritis  Nursing Times

Osteoarthritis - World Health Organization (WHO)

Osteoarthritis  World Health Organization (WHO)

Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial - The Lancet

Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial  The Lancet

The 4 Stages of Rheumatoid Arthritis Progression - CreakyJoints

The 4 Stages of Rheumatoid Arthritis Progression  CreakyJoints

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial - Nature

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial  Nature

Rheumatoid arthritis - The Lancet

Rheumatoid arthritis  The Lancet

Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease - BMC Medicine

Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease  BMC Medicine

Biological treatment in rheumatoid arthritis: when to stop? - The Lancet

Biological treatment in rheumatoid arthritis: when to stop?  The Lancet

Rheumatology - Northumbria Healthcare NHS Foundation Trust

Rheumatology  Northumbria Healthcare NHS Foundation Trust

Arthritis drug effective in treating sickest COVID-19 patients - Imperial College London

Arthritis drug effective in treating sickest COVID-19 patients  Imperial College London

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials - The Lancet

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials  The Lancet

Arthritis drugs may reduce mortality and time in ICU for sickest COVID patients - Imperial College London

Arthritis drugs may reduce mortality and time in ICU for sickest COVID patients  Imperial College London

Rheumatoid arthritis diagnosis and management: a clinical update - Nursing Times

Rheumatoid arthritis diagnosis and management: a clinical update  Nursing Times

Rheumatoid arthritis - The Lancet

Rheumatoid arthritis  The Lancet

The N-Formyl Peptide Receptors and Rheumatoid Arthritis: A Dangerous Liaison or Confusing Relationship? - Frontiers

The N-Formyl Peptide Receptors and Rheumatoid Arthritis: A Dangerous Liaison or Confusing Relationship?  Frontiers

Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK - The BMJ

Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK  The BMJ

Rheumatoid Arthritis & Jaw Pain: Here's How to Deal - HealthCentral

Rheumatoid Arthritis & Jaw Pain: Here's How to Deal  HealthCentral

Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study - The Lancet

Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study  The Lancet

Transcriptomic profiling of programmed cell death 1 (PD-1) expressing T cells in early rheumatoid arthritis identifies a decreased CD4 + PD-1 + signature post-treatment - Nature

Transcriptomic profiling of programmed cell death 1 (PD-1) expressing T cells in early rheumatoid arthritis identifies a decreased CD4 + PD-1 + signature post-treatment  Nature

Blocking the immune system in rheumatoid arthritis - The Pharmaceutical Journal

Blocking the immune system in rheumatoid arthritis  The Pharmaceutical Journal

Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELY - The Lancet

Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELY  The Lancet

Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts - The Lancet

Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts  The Lancet

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren's disease - ndph.ox.ac.uk

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren's disease  ndph.ox.ac.uk

Biological disease‐modifying drugs for rheumatoid arthritis - Chaplin - 2020 - Prescriber - Wiley Online Library

Biological disease‐modifying drugs for rheumatoid arthritis - Chaplin - 2020 - Prescriber  Wiley Online Library

PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial - BioMed Central

PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial  BioMed Central

Sustained Remission with Etanercept Tapering in Early Rheumatoid Arthritis - NEJM

Sustained Remission with Etanercept Tapering in Early Rheumatoid Arthritis  NEJM

Rheumatoid arthritis - Nature

Rheumatoid arthritis  Nature

Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol - BioMed Central

Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol  BioMed Central

Cholesterol Levels and Rheumatoid Arthritis: What's the Link? - HealthCentral

Cholesterol Levels and Rheumatoid Arthritis: What's the Link?  HealthCentral

Suspicious Symptoms Herald Early Rheumatoid Arthritis - HCPLive

Suspicious Symptoms Herald Early Rheumatoid Arthritis  HCPLive

Early Menopause, Hormone Replacement Therapy May Raise Rheumatoid Arthritis Risk - Healthline

Early Menopause, Hormone Replacement Therapy May Raise Rheumatoid Arthritis Risk  Healthline

Palliative care - World Health Organization (WHO)

Palliative care  World Health Organization (WHO)

Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission - Nature

Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission  Nature

6 Common Questions About Taking Prednisone for Rheumatoid Arthritis - CreakyJoints

6 Common Questions About Taking Prednisone for Rheumatoid Arthritis  CreakyJoints

Rheumatoid arthritis: management - The Pharmaceutical Journal

Rheumatoid arthritis: management  The Pharmaceutical Journal

UK waiting times for RA and PsA patients: an interview with Dr Marwan Bukhari, Consultant Rheumatologist at the University Hospitals of Morecambe Bay NHS Foundation Trust - News-Medical

UK waiting times for RA and PsA patients: an interview with Dr Marwan Bukhari, Consultant Rheumatologist at the University Hospitals of Morecambe Bay NHS Foundation Trust  News-Medical

Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis - Nature

Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis  Nature

10 Natural remedies for rheumatoid arthritis - Medical News Today

10 Natural remedies for rheumatoid arthritis  Medical News Today

Osteoarthritis in primary care: early diagnosis and management - GPonline

Osteoarthritis in primary care: early diagnosis and management  GPonline

Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics - Nature

Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics  Nature

(PDF) Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial - ResearchGate

(PDF) Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial  ResearchGate

CAR T-cell therapy may be a ‘miracle,' but it is too soon to say ‘cure' - Healio

CAR T-cell therapy may be a ‘miracle,' but it is too soon to say ‘cure'  Healio

Arthritis warning: The healthy foods that can actually trigger arthritis symptoms - Daily Express

Arthritis warning: The healthy foods that can actually trigger arthritis symptoms  Daily Express

Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health - Nature

Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health  Nature

Strictly's Adam Thomas 'may need medication for life' for chronic illness - Metro.co.uk

Strictly's Adam Thomas 'may need medication for life' for chronic illness  Metro.co.uk

Fig 2. Predicted Group Trajectories in Early Rheumatoid Arthritis based... - ResearchGate

Fig 2. Predicted Group Trajectories in Early Rheumatoid Arthritis based...  ResearchGate

Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients - Nature

Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients  Nature

Rheumatoid arthritis: Overweight and obese people at greater risk - Daily Express

Rheumatoid arthritis: Overweight and obese people at greater risk  Daily Express

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial - The Lancet

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial  The Lancet

Early Treatment Improves Rheumatoid Arthritis Symptoms, Helps Patients Live Longer, Study Suggests - rheumatoidarthritisnews.com

Early Treatment Improves Rheumatoid Arthritis Symptoms, Helps Patients Live Longer, Study Suggests  rheumatoidarthritisnews.com

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis - NEJM

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis  NEJM

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis - NEJM

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis  NEJM

The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis - NEJM

The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis  NEJM